Literature DB >> 12076138

Synthesis of alpha-D-Galp-(1-->3)-beta-D-Galf-(1-->3)-D-man, a terminal trisaccharide of Leishmania type-2 glycoinositolphospholipids.

Lucia Gandolfi-Donadio1, Carola Gallo-Rodriguez, Rosa M de Lederkremer.   

Abstract

The synthesis of alpha-D-Galp-(1-->3)-beta-D-Galf-(1-->3)-D-Man, present in the type-2 glycoinositolphospholipids and in the core of the lipophosphoglycan of Leishmania, is described. The glycosyl aldonolactone approach, followed by reduction of the lactone with diisoamylborane, was utilized for the introduction of the internal galactofuranosyl unit and the trichloroacetimidate method for the O-glycosidation reaction. A high-yield synthesis of the beta-D-Galf-(1-3)-D-Man unit, also present in the lipopeptidophosphoglycan of Trypanosoma cruzi, is reported.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076138     DOI: 10.1021/jo016290z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  AuBr(3) mediated glycosidations: synthesis of tetrasaccharide motif of the Leishmania donovani lipophosphoglycan.

Authors:  Gopalsamy Sureshkumar; Srinivas Hotha
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

2.  Reversed Immunoglycomics Identifies α-Galactosyl-Bearing Glycotopes Specific for Leishmania major Infection.

Authors:  Alba L Montoya; Victoria M Austin; Susana Portillo; Irodiel Vinales; Roger A Ashmus; Igor Estevao; Sohan R Jankuru; Yasser Alraey; Waleed S Al-Salem; Álvaro Acosta-Serrano; Igor C Almeida; Katja Michael
Journal:  JACS Au       Date:  2021-07-12

3.  Specific Recognition of β-Galactofuranose-Containing Glycans of Synthetic Neoglycoproteins by Sera of Chronic Chagas Disease Patients.

Authors:  Alba L Montoya; Eileni R Gil; Emily L Heydemann; Igor L Estevao; Bianca E Luna; Cameron C Ellis; Sohan R Jankuru; Belkisyolé Alarcón de Noya; Oscar Noya; Maria Paola Zago; Igor C Almeida; Katja Michael
Journal:  Molecules       Date:  2022-01-09       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.